» Articles » PMID: 36169768

Clinical and Neuroimaging Review of Triplet Repeat Diseases

Overview
Journal Jpn J Radiol
Publisher Springer
Specialty Radiology
Date 2022 Sep 28
PMID 36169768
Authors
Affiliations
Soon will be listed here.
Abstract

Triplet repeat diseases (TRDs) refer to a group of diseases caused by three nucleotide repeats elongated beyond a pathologic threshold. TRDs are divided into the following four groups depending on the pathomechanisms, although the pathomechanisms of several diseases remain unelucidated: polyglutamine disorders, caused by a pathologic repeat expansion of CAG (coding the amino acid glutamine) located within the exon; loss-of-function repeat disorders, characterized by the common feature of a loss of function of the gene within which they occur; RNA gain-of-function disorders, involving the production of a toxic RNA species; and polyalanine disorders, caused by a pathologic repeat expansion of GCN (coding the amino acid alanine) located within the exon. Many of these TRDs manifest through neurologic symptoms; moreover, neuroimaging, especially brain magnetic resonance imaging, plays a pivotal role in the detection of abnormalities, differentiation, and management of TRDs. In this article, we reviewed the clinical and neuroimaging features of TRDs. An early diagnosis of TRDs through clinical and imaging approaches is important and may contribute to appropriate medical intervention for patients and their families.

Citing Articles

Holoprosencephaly spectrum: an up-to-date overview of classification, genetics and neuroimaging.

Gomez G, Correa D, Trapp B, Figueiredo I, Zuppani H, Kingston S Jpn J Radiol. 2024; 43(1):13-31.

PMID: 39259418 DOI: 10.1007/s11604-024-01655-8.


Advances on the Mechanisms and Therapeutic Strategies in Non-coding CGG Repeat Expansion Diseases.

Zhang Y, Liu X, Li Z, Li H, Miao Z, Wan B Mol Neurobiol. 2024; 61(12):10722-10735.

PMID: 38780719 DOI: 10.1007/s12035-024-04239-9.


Infantile-onset parkinsonism, dyskinesia, and developmental delay: do not forget polyglutamine defects!.

Baide-Mairena H, Coget A, Leboucq N, Procaccio V, Blanluet M, Meyer P Ann Clin Transl Neurol. 2023; 10(10):1937-1943.

PMID: 37491839 PMC: 10578886. DOI: 10.1002/acn3.51858.

References
1.
La Spada A, Wilson E, Lubahn D, Harding A, Fischbeck K . Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991; 352(6330):77-9. DOI: 10.1038/352077a0. View

2.
Guerrini R, Moro F, Kato M, Barkovich A, Shiihara T, McShane M . Expansion of the first PolyA tract of ARX causes infantile spasms and status dystonicus. Neurology. 2007; 69(5):427-33. DOI: 10.1212/01.wnl.0000266594.16202.c1. View

3.
Leehey M . Fragile X-associated tremor/ataxia syndrome: clinical phenotype, diagnosis, and treatment. J Investig Med. 2009; 57(8):830-6. PMC: 2787702. DOI: 10.2310/JIM.0b013e3181af59c4. View

4.
Kim M, Ahn J, Mun J, Choi E, Kim J, Youn J . Extracerebellar Signs and Symptoms in 117 Korean Patients with Early-Stage Spinocerebellar Ataxia. J Clin Neurol. 2021; 17(2):242-248. PMC: 8053557. DOI: 10.3988/jcn.2021.17.2.242. View

5.
Harding I, Chopra S, Arrigoni F, Boesch S, Brunetti A, Cocozza S . Brain Structure and Degeneration Staging in Friedreich Ataxia: Magnetic Resonance Imaging Volumetrics from the ENIGMA-Ataxia Working Group. Ann Neurol. 2021; 90(4):570-583. PMC: 9292360. DOI: 10.1002/ana.26200. View